EPO and polycythemia: Alternatively, angiogenesis in cancer could be affected by biglycan through the stabilization HIF-2α, which is induced by TLR2 interaction with biglycan and results in the induction of erythropoietin (Epo) synthesis and polycythemia (186) (Figure 2).